Fibromuscular dysplasia

  • David P. Slovut
  • Jeffrey W. Olin

Optional statement

The most common clinical manifestations of fibromuscular dysplasia (FMD) are hypertension due to renal artery involvement and transient ischemic attack or stroke due to carotid or vertebral artery involvement. Patients with renal artery FMD and hypertension should undergo primary angioplasty with the goal of curing the hypertension. If the blood pressure fails to normalize following angioplasty, the physician should institute antihypertensive medications according to the recommendations of the Joint National Committee on the Prevention, Detection, and Treatment of High Blood Pressure VII. In patients with cerebrovascular FMD, antiplatelet agents represent the cornerstone of therapy. Percutaneous angioplasty has emerged as the preferred treatment for symptomatic cerebrovascular FMD.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    McCormack LJ, Hazard JB, Poutasse EF: Obstructive lesions of the renal artery associated with remediable hypertension [abstract]. Am J Pathol 1958, 34:582.Google Scholar
  2. 2.
    Olin JW: Syndromes that mimic vasculitis. Curr Opin Cardiol 1991, 6:768–774.CrossRefGoogle Scholar
  3. 3.
    Rybka SJ, Novick AC: Concomitant carotid, mesenteric and renal artery stenosis due to primary intimal fibroplasia. J Urol 1983, 129:798–800.PubMedGoogle Scholar
  4. 4.
    Kojima A, Shindo S, Kubota K, et al.: Successful surgical treatment of a patient with multiple visceral artery aneurysms due to fibromuscular dysplasia. Cardiovasc Surg 2002, 10:157–160.PubMedCrossRefGoogle Scholar
  5. 5.
    Stokes JB, Bonsib SM, McBride JW: Diffuse intimal fibromuscular dysplasia with multiorgan failure. Arch Intern Med 1996, 156:2611–2614.PubMedCrossRefGoogle Scholar
  6. 6.
    Luscher TF, Keller HM, Imhof HG, et al.: Fibromuscular hyperplasia: extension of the disease and therapeutic outcome. Results of the University Hospital Zurich Cooperative Study on Fibromuscular Hyperplasia. Nephron 1986, 44:109–114.PubMedGoogle Scholar
  7. 7.
    Stanley JC, Gewertz BL, Bove EL, et al.: Arterial fibrodysplasia. Histopathologic character and current etiologic concepts. Arch Surg 1975, 110:561–566.PubMedGoogle Scholar
  8. 8.
    Safian RD, Textor SC: Renal-artery stenosis. N Engl J Med 2001, 344:431–442.PubMedCrossRefGoogle Scholar
  9. 9.
    Andreoni KA, Weeks SM, Gerber DA, et al.: Incidence of donor renal fibromuscular dysplasia: does it justify routine angiography? Transplantation 2002, 73:1112–1116.PubMedCrossRefGoogle Scholar
  10. 10.
    Neymark E, La Berge JM, Hirose R, et al.: Arteriographic detection of renovascular disease in potential renal donors: incidence and effect on donor surgery. Radiology 2000, 214:755–760.PubMedGoogle Scholar
  11. 11.
    Begelman SM, Olin JW: Fibromuscular dysplasia. Curr Opin Rheumatol 2000, 12:41–47.PubMedCrossRefGoogle Scholar
  12. 12.
    Harrison EG Jr, McCormack LJ: Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin Proc 1971, 46:161–167.PubMedGoogle Scholar
  13. 13.
    Mettinger KL: Fibromuscular dysplasia and the brain. II. Current concept of the disease. Stroke 1982, 13:53–58.PubMedGoogle Scholar
  14. 14.
    Schievink WI, Bjornsson J: Fibromuscular dysplasia of the internal carotid artery: a clinicopathological study. Clin Neuropathol 1996, 15:2–6.PubMedGoogle Scholar
  15. 15.
    Corrin LS, Sandok BA, Houser OW: Cerebral ischemic events in patients with carotid artery fibromuscular dysplasia. Arch Neurol 1981, 38:616–618.PubMedGoogle Scholar
  16. 16.
    So EL, Toole JF, Dalal P, et al.: Cephalic fibromuscular dysplasia in 32 patients: clinical findings and radiologic features. Arch Neurol 1981, 38:619–622.PubMedGoogle Scholar
  17. 17.
    Wesen CA, Elliott BM: Fibromuscular dysplasia of the carotid arteries. Am J Surg 1986, 151:448–451.PubMedCrossRefGoogle Scholar
  18. 18.
    Chobanian AV, Bakris GL, Black HR, et al.: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560–2572.PubMedCrossRefGoogle Scholar
  19. 19.
    Jaff MR, Olin JW, Young JR: Failure of acute phase reactants to predict disease activity in Takayasu’s arteritis. J Vasc Med Biol 1993, 4:223–227.Google Scholar
  20. 20.
    Gowda MS, Loeb AL, Crouse LJ, et al.: Complementary roles of color-flow duplex imaging and intravascular ultrasound in the diagnosis of renal artery fibromuscular dysplasia: should renal arteriography serve as the “gold standard”? J Am Coll Cardiol 2003, 41:1305–1311. Both color-duplex ultrasonography and intravascular ultrasound were used to evaluate renal artery fibromuscular lesions. Whereas most previous Doppler studies have examined criteria for atherosclerotic renal artery stenosis, this study proposes criteria for Doppler assessment of FMD lesions.PubMedCrossRefGoogle Scholar
  21. 21.
    Carman T, Olin JW, Czum J: Noninvasive imaging of renal arteries. Urol Clin North Am 2001, 28:815–826.PubMedCrossRefGoogle Scholar
  22. 22.
    Olin JW, Piedmonte M, Young JR, et al.: Utility of duplex scanning of the renal arteries for diagnosing significant renal artery stenosis. Ann Intern Med 1995, 122:833–838.PubMedGoogle Scholar
  23. 23.
    Malatino LS, Polizzi G, Garozzo M, et al.: Diagnosis of renovascular disease by extra- and intrarenal Doppler parameters. Angiology 1998, 49:707–721.PubMedCrossRefGoogle Scholar
  24. 24.
    Riehl J, Schmitt H, Bongartz D, et al.: Renal artery stenosis: evaluation with colour duplex ultrasonography. Nephrol Dial Transplant 1997, 12:1608–1614.PubMedCrossRefGoogle Scholar
  25. 25.
    Schwerk WB, Restrepo IK, Stellwaag M, et al.: Renal artery stenosis: grading with image-directed Doppler US evaluation of renal resistive index. Radiology 1994, 190:785–790.PubMedGoogle Scholar
  26. 26.
    Marana I, Airoldi F, Burdick L, et al.: Effects of balloon angioplasty and stent implantation on intrarenal echo-Doppler velocimetric indices. Kidney Int 1998, 53:1795–1800.PubMedCrossRefGoogle Scholar
  27. 27.
    Ozbek SS, Aytac SK, Erden MI, et al.: Intrarenal Doppler findings of upstream renal artery stenosis: a preliminary report. Ultrasound Med Biol 1993, 19:3–12.PubMedCrossRefGoogle Scholar
  28. 28.
    Hetzel GR, Hollenbeck M, Voiculescu A, et al.: Effect of acute intravenous ace-inhibition on the intrarenal Doppler flow characteristics in hypertensive patients with and without unilateral renal artery stenosis. Clin Exp Hypertens 2000, 22:571–581.PubMedCrossRefGoogle Scholar
  29. 29.
    Radermacher J, Chavan A, Bleck J, et al.: Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 2001, 344:410–417.PubMedCrossRefGoogle Scholar
  30. 30.
    Adwards JM, Zaccardi MJ, Strandness DE Jr: A preliminary study of the role of duplex scanning in defining the adequacy of treatment of patients with renal artery fibromuscular dysplasia. J Vasc Surg 1992, 15:604–609; discussion 609–611.CrossRefGoogle Scholar
  31. 31.
    Kaynan AM, Rozenblit AM, Figueroa KI, et al.: Use of spiral computerized tomography in lieu of angiography for preoperative assessment of living renal donors. J Urol 1999, 161:1769–1775.PubMedCrossRefGoogle Scholar
  32. 32.
    Beregi JP, Louvegny S, Gautier C, et al.: Fibromuscular dysplasia of the renal arteries: comparison of helical CT angiography and arteriography. AJR Am J Roentgenol 1999, 172:27–34.PubMedGoogle Scholar
  33. 33.
    Rubin GD: MDCT imaging of the aorta and peripheral vessels. Eur J Radiol 2003, 45(suppl 1):S42-S49.PubMedCrossRefGoogle Scholar
  34. 34.
    Funabashi N, Komiyama N, Komuro I: Fibromuscular dysplasia in renovascular hypertension demonstrated by multislice CT: comparison with conventional angiogram and intravascular ultrasound. Heart 2003, 89:639.PubMedCrossRefGoogle Scholar
  35. 35.
    Fink C, Hallscheidt PJ, Hosch WP, et al.: Preoperative evaluation of living renal donors: value of contrastenhanced 3D magnetic resonance angiography and comparison of three rendering algorithms. Eur Radiol 2003, 13:794–801.PubMedGoogle Scholar
  36. 36.
    Marcos HB, Choyke PL: Magnetic resonance angiography of the kidney. Semin Nephrol 2000, 20:450–455.PubMedGoogle Scholar
  37. 37.
    Cragg AH, Smith TP, Thompson BH, et al.: Incidental fibromuscular dysplasia in potential renal donors: longterm clinical follow-up. Radiology 1989, 172:145–147.PubMedGoogle Scholar
  38. 38.
    Schreiber MJ, Pohl MA, Novick AC: The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am 1984, 11:383–392.PubMedGoogle Scholar
  39. 39.
    Kincaid OW, Davis GD, Hallermann FJ, et al.: Fibromuscular dysplasia of the renal arteries. Arteriographic features, classification, and observations on natural history of the disease. Am J Roentgenol Radium Ther Nucl Med 1968, 104:271–282.PubMedGoogle Scholar
  40. 40.
    Goncharenko V, Gerlock AJ Jr, Shaff MI, et al.: Progression of renal artery fibromuscular dysplasia in 42 patients as seen on angiography. Radiology 1981, 139:45–51.PubMedGoogle Scholar
  41. 41.
    Mounier-Vehier C, Lions C, Jaboureck O, et al.: Parenchymal consequences of fibromuscular dysplasia renal artery stenosis. Am J Kidney Dis 2002, 40:1138–1145.PubMedCrossRefGoogle Scholar
  42. 42.
    Mounier-Vehier C, Haulon S, Devos P, et al.: Renal atrophy outcome after revascularization in fibromuscular dysplasia disease. J Endovasc Ther 2002, 9:605–613. In patients with unilateral fibromuscular disease, spiral CTA revealed significant cortical and medullary atrophy in poststenotic kidneys compared with contralateral normal kidneys. Atrophy may serve as a marker of renal ischemia.PubMedCrossRefGoogle Scholar
  43. 43.
    Slovut DP, Olin JW: Fibromuscular dysplasia. N Engl J Med 2004, 350:1862–1871. This is the most comprehensive up-to-date review of FMD published to date.PubMedCrossRefGoogle Scholar
  44. 44.
    Sacks FM, Svetkey LP, Vollmer WM, et al.: Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001, 344:3–10.PubMedCrossRefGoogle Scholar
  45. 45.
    Mackrell PJ, Langan EM 3rd, Sullivan TM, et al.: Management of renal artery stenosis: effects of a shift from surgical to percutaneous therapy on indications and outcomes. Ann Vasc Surg 2003, 17:54–59.PubMedCrossRefGoogle Scholar
  46. 46.
    Surowiec SM, Sivamurthy N, Rhodes JM, et al.: Percutaneous therapy for renal artery fibromuscular dysplasia. Ann Vasc Surg 2003, 17:650–655.PubMedCrossRefGoogle Scholar
  47. 47.
    Jensen G, Zachrisson BF, Delin K, et al.: Treatment of renovascular hypertension: one year results of renal angioplasty. Kidney Int 1995, 48:1936–1945.PubMedCrossRefGoogle Scholar
  48. 48.
    Davidson RA, Barri Y, Wilcox CS: Predictors of cure of hypertension in fibromuscular renovascular disease. Am J Kidney Dis 1996, 28:334–338.PubMedGoogle Scholar
  49. 49.
    Bonelli FS, McKusick MA, Textor SC, et al.: Renal artery angioplasty: technical results and clinical outcome in 320 patients. Mayo Clin Proc 1995, 70:1041–1052.PubMedCrossRefGoogle Scholar
  50. 50.
    Klow NE, Paulsen D, Vatne K, et al.: Percutaneous transluminal renal artery angioplasty using the coaxial technique. Ten years of experience from 591 procedures in 419 patients. Acta Radiol 1998, 39:594–603.PubMedCrossRefGoogle Scholar
  51. 51.
    Birrer M, Do DD, Mahler F, et al.: Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study. Eur J Vasc Endovasc Surg 2002, 23:146–152.PubMedCrossRefGoogle Scholar
  52. 52.
    de Fraissinette B, Garcier JM, Dieu V, et al.: Percutaneous transluminal angioplasty of dysplastic stenoses of the renal artery: results on 70 adults. Cardiovasc Intervent Radiol 2003, 26:46–51. This retrospective study represents one of the largest contemporary series of patients with hypertension and renal artery fibromuscular disease. Technical success and clinical outcomes were excellent using balloon angioplasty of the renal artery as primary therapy.PubMedCrossRefGoogle Scholar
  53. 53.
    Airoldi F, Palatresi S, Marana I, et al.: Angioplasty of atherosclerotic and fibromuscular renal artery stenosis: time course and predicting factors of the effects on renal function. Am J Hypertens 2000, 13:1210–1217.PubMedCrossRefGoogle Scholar
  54. 54.
    Webster J, Marshall F, Abdalla M, et al.: Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998, 12:329–335.PubMedCrossRefGoogle Scholar
  55. 55.
    Bisschops RH, Popma JJ, Meyerovitz MF: Treatment of fibromuscular dysplasia and renal artery aneurysm with use of a stent-graft. J Vasc Interv Radiol 2001, 12:757–760.PubMedCrossRefGoogle Scholar
  56. 56.
    English WP, Pearce JD, Craven TE, et al.: Surgical management of renal artery aneurysms. J Vasc Surg 2004, 40:53–60.PubMedCrossRefGoogle Scholar
  57. 57.
    Pfeiffer T, Reiher L, Grabitz K, et al.: Reconstruction for renal artery aneurysm: operative techniques and longterm results. J Vasc Surg 2003, 37:293–300.PubMedCrossRefGoogle Scholar
  58. 58.
    Zeller T, Frank U, Muller C, et al.: Technological advances in the design of catheters and devices used in renal artery interventions: impact on complications. J Endovasc Ther 2003, 10:1006–1014.PubMedCrossRefGoogle Scholar
  59. 59.
    Olin JW: Atherosclerotic renal artery disease. Cardiol Clin 2002, 20:547–562; vi.PubMedCrossRefGoogle Scholar
  60. 60.
    Reiher L, Pfeiffer T, Sandmann W: Long-term results after surgical reconstruction for renal artery fibromuscular dysplasia. Eur J Vasc Endovasc Surg 2000, 20:556–559.PubMedCrossRefGoogle Scholar
  61. 61.
    Marekovic Z, Mokos I, Krhen I, et al.: Long-term outcome after surgical kidney revascularization for fibromuscular dysplasia and atherosclerotic renal artery stenosis. J Urol 2004, 171:1043–1045.PubMedCrossRefGoogle Scholar
  62. 62.
    Luscher TF, Lie JT, Stanson AW, et al.: Arterial fibromuscular dysplasia. Mayo Clin Proc 1987, 62:931–952.PubMedGoogle Scholar
  63. 63.
    Novick AC, Ziegelbaum M, Vidt DG, et al.: Trends in surgical revascularization for renal artery disease. Ten years’ experience. JAMA 1987, 257:498–501.PubMedCrossRefGoogle Scholar
  64. 64.
    Van Damme H, Sakalihasan N, Limet R: Fibromuscular dysplasia of the internal carotid artery. Personal experience with 13 cases and literature review. Acta Chir Belg 1999, 99:163–168.PubMedGoogle Scholar
  65. 65.
    Mettinger KL, Ericson K: Fibromuscular dysplasia and the brain. I. Observations on angiographic, clinical and genetic characteristics. Stroke 1982, 13:46–52.PubMedGoogle Scholar
  66. 66.
    Wells RP, Smith RR: Fibromuscular dysplasia of the internal carotid artery: a long term follow-up. Neurosurgery 1982, 10:39–43.PubMedCrossRefGoogle Scholar
  67. 67.
    Leary MC, Finley A, Caplan LR: Cerebrovascular complications of fibromuscular dysplasia. Curr Treat Options Cardiovasc Med 2004, 6:237–248.PubMedGoogle Scholar
  68. 68.
    Chiche L, Bahnini A, Koskas F, et al.: Occlusive fibromuscular disease of arteries supplying the brain: results of surgical treatment. Ann Vasc Surg 1997, 11:496–504.PubMedCrossRefGoogle Scholar
  69. 69.
    Effeney DJ, Krupski WC, Stoney RJ, et al.: Fibromuscular dysplasia of the carotid artery. Aust N Z J Surg 1983, 53:527–531.PubMedGoogle Scholar
  70. 70.
    Cloft HJ, Kallmes DF, Kallmes MH, et al.: Prevalence of cerebral aneurysms in patients with fibromuscular dysplasia: a reassessment. J Neurosurg 1998, 88:436–440.PubMedCrossRefGoogle Scholar
  71. 71.
    Rinkel GJ, Djibuti M, Algra A, et al.: Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke 1998, 29:251–256.PubMedGoogle Scholar
  72. 72.
    Arning C: Nonatherosclerotic disease of the cervical arteries: role of ultrasonography for diagnosis. Vasa 2001, 30:160–167.PubMedCrossRefGoogle Scholar
  73. 73.
    Furie DM, Tien RD: Fibromuscular dysplasia of arteries of the head and neck: imaging findings. AJR Am J Roentgenol 1994, 162:1205–1209.PubMedGoogle Scholar
  74. 74.
    Stewart MT, Moritz MW, Smith RB 3rd, et al.: The natural history of carotid fibromuscular dysplasia. J Vasc Surg 1986, 3:305–310.PubMedCrossRefGoogle Scholar
  75. 75.
    Collins GJ Jr, Rich NM, Clagett GP, et al.: Fibromuscular dysplasia of the internal carotid arteries. Clinical experience and follow-up. Ann Surg 1981, 194:89–96.PubMedCrossRefGoogle Scholar
  76. 76.
    Starr DS, Lawrie GM, Morris GC Jr: Fibromuscular disease of carotid arteries: long-term results of graduated internal dilatation. Stroke 1981, 12:196–199.PubMedGoogle Scholar
  77. 77.
    Moreau P, Albat B, Thevenet A: Fibromuscular dysplasia of the internal carotid artery: long-term surgical results. J Cardiovasc Surg (Torino) 1993, 34:465–472.Google Scholar
  78. 78.
    Martin EC, Diamond NG, Casarella WJ: Percutaneous transluminal angioplasty in non-atherosclerotic disease. Radiology 1980, 135:27–33.PubMedGoogle Scholar
  79. 79.
    Smith LL, Smith DC, Killeen JD, et al.: Operative balloon angioplasty in the treatment of internal carotid artery fibromuscular dysplasia. J Vasc Surg 1987, 6:482–487.PubMedCrossRefGoogle Scholar
  80. 80.
    Finsterer J, Strassegger J, Haymerle A, et al.: Bilateral stenting of symptomatic and asymptomatic internal carotid artery stenosis due to fibromuscular dysplasia. J Neurol Neurosurg Psychiatry 2000, 69:683–686.PubMedCrossRefGoogle Scholar
  81. 81.
    Faggioli GL, Freyrie A, Stella A, et al.: Extracranial internal carotid artery aneurysms: results of a surgical series with long-term follow-up. J Vasc Surg 1996, 23:587–594; discussion 594–585.PubMedCrossRefGoogle Scholar
  82. 82.
    Bour P, Taghavi I, Bracard S, et al.: Aneurysms of the extracranial internal carotid artery due to fibromuscular dysplasia: results of surgical management. Ann Vasc Surg 1992, 6:205–208.PubMedCrossRefGoogle Scholar
  83. 83.
    Brown MM: Balloon angioplasty for cerebrovascular disease. Neurol Res 1992, 14:159–163.PubMedCrossRefGoogle Scholar
  84. 84.
    Ohki T, Veith FJ, Grenell S, et al.: Initial experience with cerebral protection devices to prevent embolization during carotid artery stenting. J Vasc Surg 2002, 36:1175–1185.PubMedCrossRefGoogle Scholar
  85. 85.
    Henry M, Henry I, Klonaris C, et al.: Benefits of cerebral protection during carotid stenting with the Percu-Surge GuardWire system: midterm results. J Endovasc Ther 2002, 9:1–13.PubMedCrossRefGoogle Scholar
  86. 86.
    Sauer L, Reilly LM, Goldstone J, et al.: Clinical spectrum of symptomatic external iliac fibromuscular dysplasia. J Vasc Surg 1990, 12:488–495; discussion 495–486.PubMedCrossRefGoogle Scholar
  87. 87.
    Yoshida T, Ohashi I, Suzuki S, et al.: Fibromuscular disease of the brachial artery with digital emboli treated effectively by transluminal angioplasty. Cardiovasc Intervent Radiol 1994, 17:99–101.PubMedCrossRefGoogle Scholar
  88. 88.
    Mandke JV, Sharma S, Phatak AM, et al.: Catheter atherectomy of intimal fibroplasia of the common iliac artery. Cathet Cardiovasc Diagn 1993, 30:30–32.PubMedCrossRefGoogle Scholar
  89. 89.
    Hamed RM, Ghandour K: Abdominal angina and intestinal gangrene—a catastrophic presentation of arterial fibromuscular dysplasia: case report and review of the literature. J Pediatr Surg 1997, 32:1379–1380.PubMedCrossRefGoogle Scholar
  90. 90.
    Horie T, Seino Y, Miyauchi Y, et al.: Unusual petal-like fibromuscular dysplasia as a cause of acute abdomen and circulatory shock. Jpn Heart J 2002, 43:301–305.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc. 2005

Authors and Affiliations

  • David P. Slovut
  • Jeffrey W. Olin
    • 1
  1. 1.Mount Sinai School of MedicineThe Zena and Michael A. Wiener Cardiovascular InstituteNew YorkUSA

Personalised recommendations